Mitsubishi Gas Chemical Company, Inc.
Mitsubishi Gas Chemical Company, Inc. (MBGCF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Mitsubishi Gas Chemical Company, Inc. (MBGCF), featuring income statements, balance sheets, and cash flow data.
Mitsubishi Gas Chemical Company, Inc. (MBGCF) Income Statement & Financial Overview
View the income breakdown for Mitsubishi Gas Chemical Company, Inc. MBGCF across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $190.40B | $195.06B | $200.01B | $188.12B |
| Cost of Revenue | $155.36B | $155.21B | $153.86B | $144.87B |
| Gross Profit | $35.04B | $39.85B | $46.15B | $43.25B |
| Gross Profit Ratio | $0.18 | $0.20 | $0.23 | $0.23 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $29.48B | $28.73B | $27.73B | $27.52B |
| Operating Expenses | $29.48B | $28.31B | $28.13B | $27.52B |
| Total Costs & Expenses | $184.84B | $183.52B | $181.99B | $172.39B |
| Interest Income | $643.00M | $449.00M | $453.00M | $296.00M |
| Interest Expense | $602.00M | $345.00M | $541.00M | $886.00M |
| Depreciation & Amortization | $9.50B | $9.16B | $8.88B | -$15.33B |
| EBITDA | $15.53B | $20.28B | $27.30B | $0.00 |
| EBITDA Ratio | $0.08 | $0.10 | $0.14 | $0.00 |
| Operating Income | $5.56B | $11.54B | $18.02B | $15.73B |
| Operating Income Ratio | $0.03 | $0.06 | $0.09 | $0.08 |
| Other Income/Expenses (Net) | -$1.02B | $3.38B | $907.00M | $2.23B |
| Income Before Tax | $4.54B | $14.92B | $18.93B | $17.95B |
| Income Before Tax Ratio | $0.02 | $0.08 | $0.09 | $0.10 |
| Income Tax Expense | -$5.65B | $2.50B | $4.14B | $4.43B |
| Net Income | $9.91B | $10.91B | $12.99B | $11.73B |
| Net Income Ratio | $0.05 | $0.06 | $0.06 | $0.06 |
| EPS | $50.61 | $54.69 | $64.87 | $58.60 |
| Diluted EPS | $50.61 | $54.69 | $64.87 | $58.60 |
| Weighted Avg Shares Outstanding | $195.75M | $199.52M | $200.26M | $200.22M |
| Weighted Avg Shares Outstanding (Diluted) | $195.75M | $199.52M | $200.26M | $200.22M |
Financial performance has remained strong, with revenue growing from $188.12B in Q1 2024 to $190.40B in Q4 2024. Gross profit continued to perform well, with margins at 18% in the latest quarter. Operating income reached $5.56B in Q4 2024, holding a steady 3% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $15.53B. Net income dropped to $9.91B, keeping EPS at $50.61. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan